{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:44:01Z","timestamp":1791233041285,"version":"4.1.0"},"reference-count":79,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018712","name":"\u201cIuliu Hatieganu\u201d University of Medicine and Pharmacy Cluj-Napoca","doi-asserted-by":"crossref","award":["32153\/7\/16.12.2024"],"award-info":[{"award-number":["32153\/7\/16.12.2024"]}],"id":[{"id":"10.13039\/501100018712","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>MicroRNAs (miRNAs) have emerged as critical post-transcriptional regulators in melanoma and non-melanoma skin cancers (NMSCs), yet their full biological and clinical significance remains incompletely defined. This review synthesizes current evidence on miRNA dysregulation across basal cell carcinoma (BCC), cutaneous squamous cell carcinoma (cSCC), Merkel cell carcinoma (MCC), and melanoma, emphasizing their diagnostic, prognostic, and therapeutic relevance. In BCC, distinct miRNA expression signatures differentiate tumor tissue from normal skin and correlate with histopathological subtypes. miR-383-5p, miR-4705, miR-145-5p, and miR-18a show strong diagnostic potential, while downregulation of miR-34a is consistently associated with greater tumor aggressiveness. Subtype-specific profiles further delineate superficial versus infiltrative lesions, highlighting miRNAs as markers of tumor behavior. cSCC similarly demonstrates characteristic miRNA alterations. miR-31 is markedly upregulated during the transition from actinic keratosis to invasive carcinoma, whereas high miR-205 and low miR-203 levels correlate with poor and favorable prognosis, respectively. Regarding MCC, many miRNAs such as miR-375 and miR-182 may present a clinical value for potential biomarkers, as they are upregulated in MCC. Merkel cell carcinoma has also been linked with Merkel cell polyomavirus (MCPyV). Melanoma exhibits a complex miRNA landscape, including oncogenic miR-18a-5p and miR-146a, and tumor-suppressive miR-128-3p. Several miRNAs correlate with metastatic potential, BRAF mutation status, and therapeutic resistance, particularly miR-181a\/b, underscoring their potential as predictive biomarkers. Overall, current evidence supports miRNAs as promising diagnostic, prognostic, and predictive biomarkers in cutaneous oncology. Standardized methodologies and large-scale validation remain essential for their integration into routine clinical practice.<\/jats:p>","DOI":"10.3390\/diagnostics16010051","type":"journal-article","created":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T14:27:47Z","timestamp":1766500067000},"page":"51","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["MicroRNAs as Diagnostic and Prognostic Biomarkers in Melanoma and Non-Melanoma Skin Cancers: An Updated Review"],"prefix":"10.3390","volume":"16","author":[{"given":"Alexandra","family":"Oiegar","sequence":"first","affiliation":[{"name":"Department of Dermatology, \u201cIuliu Hatieganu\u201d University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9397-0791","authenticated-orcid":false,"given":"Adrian Bogdan","family":"Tigu","sequence":"additional","affiliation":[{"name":"Personalized Medicine and Rare Diseases Department, MEDFUTURE\u2014Institute for Biomedical Research, \u201cIuliu Ha\u021bieganu\u201d University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Baican","sequence":"additional","affiliation":[{"name":"Department of Dermatology, \u201cIuliu Hatieganu\u201d University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeta","family":"Candrea","sequence":"additional","affiliation":[{"name":"Department of Dermatology, \u201cIuliu Hatieganu\u201d University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mircea","family":"Negrutiu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, \u201cIuliu Hatieganu\u201d University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0968-4026","authenticated-orcid":false,"given":"Sorina","family":"Danescu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, \u201cIuliu Hatieganu\u201d University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,12,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Tamas, T., Raduly, L., Berindan-Neagoe, I., Dinu, C., Botan, E., Bumbu, B., Tamas, A., Stoia, S., Leucuta, D.C., and Bran, S. (2023). The Role of miRNA-221 and miRNA-34a in Non-Melanoma Skin Cancer of the Head and Neck Region. Genes, 14.","DOI":"10.3390\/genes14020503"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Wang, Y., Sun, B., Wen, X., Hao, D., Du, D., He, G., and Jiang, X. (2020). The Roles of lncRNA in Cutaneous Squamous Cell Carcinoma. Front. Oncol., 10.","DOI":"10.3389\/fonc.2020.00158"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Neagu, M., Constantin, C., Cretoiu, S.M., and Zurac, S. (2020). miRNAs in the Diagnosis and Prognosis of Skin Cancer. Front. Cell Dev. Biol., 8.","DOI":"10.3389\/fcell.2020.00071"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Nikolouzakis, T.K., Falzone, L., Lasithiotakis, K., Kr\u00fcger-Krasagakis, S., Kalogeraki, A., Sifaki, M., Spandidos, D.A., Chrysos, E., Tsatsakis, A., and Tsiaoussis, J. (2020). Current and Future Trends in Molecular Biomarkers for Diagnostic, Prognostic, and Predictive Purposes in Non-Melanoma Skin Cancer. J. Clin. Med., 9.","DOI":"10.3390\/jcm9092868"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Poniewierska-Baran, A., Zadroga, \u0141., Danilyan, E., Ma\u0142kowska, P., Nied\u017awiedzka-Rystwej, P., and Pawlik, A. (2023). MicroRNA as a Diagnostic Tool, Therapeutic Target and Potential Biomarker in Cutaneous Malignant Melanoma Detection-Narrative Review. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24065386"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Giunta, E.F., Arrichiello, G., Curvietto, M., Pappalardo, A., Bosso, D., Rosanova, M., Diana, A., Giordano, P., Petrillo, A., and Federico, P. (2021). Epigenetic Regulation in Melanoma: Facts and Hopes. Cells, 10.","DOI":"10.3390\/cells10082048"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Tamas, T., Baciut, M., Nutu, A., Bran, S., Armencea, G., Stoia, S., Manea, A., Crisan, L., Opris, H., and Onisor, F. (2021). Is miRNA Regulation the Key to Controlling Non-Melanoma Skin Cancer Evolution?. Genes, 12.","DOI":"10.3390\/genes12121929"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Xu, M., Yan, J., Wang, X., Zhang, Y., and Yang, S. (2025). New insights into microRNA in dermatological diseases. Front. Med., 12.","DOI":"10.3389\/fmed.2025.1624085"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"721","DOI":"10.2147\/DDDT.S288859","article-title":"The Risks of miRNA Therapeutics: In a Drug Target Perspective","volume":"15","author":"Zhang","year":"2021","journal-title":"Drug Des. Devel Ther."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13046-025-03391-x","article-title":"MicroRNA in cancer therapy: Breakthroughs and challenges in early clinical applications","volume":"44","author":"Martino","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nrd3179","article-title":"Targeting microRNAs in cancer: Rationale, strategies and challenges","volume":"9","author":"Garzon","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Tigu, A.B., Ivancuta, A., Uhl, A., Sabo, A.C., Nistor, M., Mure\u0219an, X.M., Cenariu, D., Timis, T., Diculescu, D., and Gulei, D. (2025). Epigenetic Therapies in Melanoma-Targeting DNA Methylation and Histone Modification. Biomedicines, 13.","DOI":"10.3390\/biomedicines13051188"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Di Vincenzo, M., Diotallevi, F., Piccirillo, S., Carnevale, G., Offidani, A., Campanati, A., and Orciani, M. (2023). miRNAs, Mesenchymal Stromal Cells and Major Neoplastic and Inflammatory Skin Diseases: A Page Being Written: A Systematic Review. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24108502"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1080\/14737159.2022.2049243","article-title":"Circulating microRNA biomarkers in melanoma and non-melanoma skin cancer","volume":"22","author":"Durante","year":"2022","journal-title":"Expert. Rev. Mol. Diagn."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11864-019-0610-0","article-title":"Diagnosis and Management of Basal Cell Carcinoma","volume":"20","author":"Tanese","year":"2019","journal-title":"Curr. Treat. Options Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.hoc.2018.09.004","article-title":"Basal Cell Carcinoma Review","volume":"33","author":"Kim","year":"2019","journal-title":"Hematol. Oncol. Clin. North. Am."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Kilgour, J.M., Jia, J.L., and Sarin, K.Y. (2021). Review of the Molecular Genetics of Basal Cell Carcinoma; Inherited Susceptibility, Somatic Mutations, and Targeted Therapeutics. Cancers, 13.","DOI":"10.3390\/cancers13153870"},{"key":"ref_18","unstructured":"Hadian, Y., Howell, J.Y., Ramsey, M.L., and Chris, B. (2025, November 13). Cutaneous Squamous Cell Carcinoma, StatPearls [Internet], Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK441939."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Hedberg, M.L., Berry, C.T., Moshiri, A.S., Xiang, Y., Yeh, C.J., Attilasoy, C., Capell, B.C., and Seykora, J.T. (2022). Molecular Mechanisms of Cutaneous Squamous Cell Carcinoma. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23073478"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/ced.14530","article-title":"Merkel cell carcinoma","volume":"46","author":"Patel","year":"2021","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Konstatinell, A., Coucheron, D.H., Sveinbj\u00f8rnsson, B., and Moens, U. (2018). MicroRNAs as Potential Biomarkers in Merkel Cell Carcinoma. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19071873"},{"key":"ref_22","unstructured":"Heistein, J.B., Acharya, U., and Mukkamalla, S.K.R. (2025). Malignant Melanoma. StatPearls [Internet], StatPearls Publishing."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1186\/s12935-022-02738-0","article-title":"Current understanding of epigenetics role in melanoma treatment and resistance","volume":"22","author":"Azargoonjahromi","year":"2022","journal-title":"Cancer Cell Int."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"14612","DOI":"10.1002\/jcp.28181","article-title":"Immune therapy of melanoma: Overview of therapeutic vaccines","volume":"234","author":"Payandeh","year":"2019","journal-title":"J. Cell Physiol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Eddy, K., and Chen, S. (2020). Overcoming Immune Evasion in Melanoma. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21238984"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Antonova, E., Hambikova, A., Shcherbakov, D., Sukhov, V., Vysochanskaya, S., Fadeeva, I., Gorshenin, D., Sidorova, E., Kashutina, M., and Zhdanova, A. (2023). Determination of Common microRNA Biomarker Candidates in Stage IV Melanoma Patients and a Human Melanoma Cell Line: A Potential Anti-Melanoma Agent Screening Model. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24119160"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/jcp.25056","article-title":"MicroRNA as Biomarkers and Diagnostics","volume":"231","author":"Wang","year":"2016","journal-title":"J. Cell Physiol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Nik Mohamed Kamal, N.N.S.B., and Shahidan, W.N.S. (2020). Non-Exosomal and Exosomal Circulatory MicroRNAs: Which Are More Valid as Biomarkers?. Front. Pharmacol., 10.","DOI":"10.3389\/fphar.2019.01500"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"15004","DOI":"10.1038\/sigtrans.2015.4","article-title":"The role of MicroRNAs in human cancer","volume":"1","author":"Peng","year":"2016","journal-title":"Sig Transduct. Target. Ther."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrd.2016.246","article-title":"MicroRNA therapeutics: Towards a new era for the management of cancer and other diseases","volume":"16","author":"Rupaimoole","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"5451","DOI":"10.1002\/jcp.27486","article-title":"An overview of microRNAs: Biology, functions, therapeutics, and analysis methods","volume":"234","author":"Saliminejad","year":"2019","journal-title":"J. Cell Physiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.cell.2015.07.008","article-title":"A Biogenesis Step Upstream of Microprocessor Controls miR-17\u223c92 Expression","volume":"162","author":"Du","year":"2015","journal-title":"Cell"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.cca.2021.01.008","article-title":"Circulating microRNAs: Biomarkers of disease","volume":"516","author":"Wu","year":"2021","journal-title":"Clin. Chim. Acta"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Leidinger, P., Keller, A., Borries, A., Reichrath, J., Rass, K., Jager, S.U., Lenhof, H.P., and Meese, E. (2010). High-throughput miRNA profiling of human melanoma blood samples. BMC Cancer, 10.","DOI":"10.1186\/1471-2407-10-262"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Komina, A., Palkina, N., Aksenenko, M., Tsyrenzhapova, S., and Ruksha, T. (2016). Antiproliferative and Pro-Apoptotic Effects of MiR-4286 Inhibition in Melanoma Cells. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0168229"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/bjc.2017.477","article-title":"Development and validation of a plasma-based melanoma biomarker suitable for clinical use","volume":"118","author":"Lincoln","year":"2018","journal-title":"Br. J. Cancer"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"6370","DOI":"10.1002\/jcp.26481","article-title":"Exosomal miRNAs as novel cancer biomarkers: Challenges and opportunities","volume":"233","author":"Salehi","year":"2018","journal-title":"J. Cell Physiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/j.1365-2133.2012.11022.x","article-title":"Expression of microRNAs in basal cell carcinoma","volume":"167","author":"Sand","year":"2012","journal-title":"Br. J. Dermatol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jdermsci.2017.01.012","article-title":"Expression of oncogenic miR-17-92 and tumor suppressive miR-143-145 clusters in basal cell carcinoma and cutaneous squamous cell carcinoma","volume":"86","author":"Sand","year":"2017","journal-title":"J. Dermatol. Sci."},{"key":"ref_40","first-page":"1283","article-title":"Expression of miR-34a in basal cell carcinoma patients and its relationship with prognosis","volume":"24","author":"Hu","year":"2019","journal-title":"J. BUON"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"100286","DOI":"10.1016\/j.xjidi.2024.100286","article-title":"MicroRNA Signatures Associated with Basal Cell Carcinoma Subtypes","volume":"4","author":"Fastner","year":"2024","journal-title":"JID Innov."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/mgg3.473","article-title":"MicroRNA-451a acts as tumor suppressor in cutaneous basal cell carcinoma","volume":"6","author":"Sun","year":"2018","journal-title":"Mol. Genet. Genomic Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1111\/ced.14322","article-title":"miR-18a expression in basal cell carcinoma and regulatory mechanism on autophagy through mTOR pathway","volume":"45","author":"Mi","year":"2020","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e187","DOI":"10.1111\/bjd.15508","article-title":"Initial in vitro functional characterization of serum exosomal microRNAs from patients with metastatic basal cell carcinoma","volume":"177","author":"Chang","year":"2017","journal-title":"Br. J. Dermatol."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Conley, J., Genenger, B., Ashford, B., and Ranson, M. (2024). Micro RNA Dysregulation in Keratinocyte Carcinomas: Clinical Evidence, Functional Impact, and Future Directions. Int. J. Mol. Sci., 25.","DOI":"10.20944\/preprints202407.1323.v1"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.drudis.2018.01.023","article-title":"The microRNA landscape of cutaneous squamous cell carcinoma","volume":"23","author":"Konicke","year":"2018","journal-title":"Drug Discov. Today"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Wang, A., Land\u00e9n, N.X., Meisgen, F., Lohcharoenkal, W., St\u00e5hle, M., Sonkoly, E., and Pivarcsi, A. (2014). MicroRNA-31 is overexpressed in cutaneous squamous cell carcinoma and regulates cell motility and colony formation ability of tumor cells. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0103206"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.3892\/ol.2017.5554","article-title":"MicroRNA-31 functions as an oncogenic microRNA in cutaneous squamous cell carcinoma cells by targeting RhoTBT1","volume":"13","author":"Lin","year":"2017","journal-title":"Oncol. Lett."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"13151","DOI":"10.2147\/OTT.S271346","article-title":"The Current State of Research Regarding the Role of Non-Coding RNAs in Cutaneous Squamous Cell Carcinoma","volume":"13","author":"Chen","year":"2020","journal-title":"Onco Targets Ther."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/bjd.15236","article-title":"MicroRNA (miR)-203 and miR-205 expression patterns identify subgroups of prognosis in cutaneous squamous cell carcinoma","volume":"177","author":"Valero","year":"2017","journal-title":"Br. J. Dermatol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s11658-018-0131-z","article-title":"miRNA-221 promotes cutaneous squamous cell carcinoma progression by targeting PTEN","volume":"24","author":"Gong","year":"2019","journal-title":"Cell Mol. Biol. Lett."},{"key":"ref_52","first-page":"11446","article-title":"Decreased expression of microRNA-20a promotes tumor progression and predicts poor prognosis of cutaneous squamous cell carcinoma","volume":"8","author":"Zhang","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1007\/s13277-015-4046-2","article-title":"MicroRNA-346 functions as an oncogene in cutaneous squamous cell carcinoma","volume":"37","author":"Chen","year":"2016","journal-title":"Tumour Biol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s13671-014-0068-z","article-title":"Merkel Cell Carcinoma: Epidemiology, Target, and Therapy","volume":"3","author":"Hughes","year":"2014","journal-title":"Curr. Dermatol. Rep."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"289548","DOI":"10.1155\/2014\/289548","article-title":"Characterization of the Merkel Cell Carcinoma miRNome","volume":"2014","author":"Ning","year":"2014","journal-title":"J. Skin. Cancer"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jid.2019.06.135","article-title":"MCPyV Large T Antigen-Induced Atonal Homolog 1 Is a Lineage-Dependency Oncogene in Merkel Cell Carcinoma","volume":"140","author":"Fan","year":"2020","journal-title":"J. Invest. Dermatol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1010428317701646","DOI":"10.1177\/1010428317701646","article-title":"Identification of plasma microRNAs as new potential biomarkers with high diagnostic power in human cutaneous melanoma","volume":"39","author":"Fogli","year":"2017","journal-title":"Tumour Biol."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Sol\u00e9, C., Tramonti, D., Schramm, M., Goicoechea, I., Armesto, M., Hernandez, L.I., Manterola, L., Fernandez-Mercado, M., Mujika, K., and Tuneu, A. (2019). The Circulating Transcriptome as a Source of Biomarkers for Melanoma. Cancers, 11.","DOI":"10.3390\/cancers11010070"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/modpathol.2016.44","article-title":"microRNA in situ hybridization for miR-211 detection as an ancillary test in melanoma diagnosis","volume":"29","author":"Babapoor","year":"2016","journal-title":"Mod. Pathol."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Barbato, A., Iuliano, A., Volpe, M., D\u2019Alterio, R., Brillante, S., Massa, F., De Cegli, R., Carrella, S., Salati, M., and Russo, A. (2021). Integrated Genomics Identifies miR-181\/TFAM Pathway as a Critical Driver of Drug Resistance in Melanoma. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22041801"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Zhou, X., He, J., Wang, Q., and Ma, T. (2021). MiRNA-128-3p Restrains Malignant Melanoma Cell Malignancy by Targeting NTRK3. Front. Oncol., 10.","DOI":"10.3389\/fonc.2020.538894"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3892\/mmr.2020.11717","article-title":"miR 18a 5p promotes melanoma cell proliferation and inhibits apoptosis and autophagy by targeting EPHA7 signaling","volume":"23","author":"Guo","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1158\/0008-5472.CAN-07-2538","article-title":"The Promyelocytic Leukemia Zinc Finger\u2013MicroRNA-221\/-222 Pathway Controls Melanoma Progression through Multiple Oncogenic Mechanisms","volume":"68","author":"Felicetti","year":"2008","journal-title":"Cancer Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jdermsci.2010.12.010","article-title":"The circulating microRNA-221 level in patients with malignant melanoma as a new tumor marker","volume":"61","author":"Kanemaru","year":"2011","journal-title":"J. Dermatol. Sci."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/ijc.28097","article-title":"The abrogation of the HOXB7\/PBX2 complex induces apoptosis in melanoma through the miR-221&222-c-FOS pathway","volume":"133","author":"Errico","year":"2013","journal-title":"Int. J. Cancer"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Aksenenko, M., Palkina, N., Komina, A., Tashireva, L., and Ruksha, T. (2019). Differences in microRNA expression between melanoma and healthy adjacent skin. BMC Dermatol., 19.","DOI":"10.1186\/s12895-018-0081-1"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.molimm.2013.11.018","article-title":"Circulating immune cell and microRNA in patients with uveal melanoma developing metastatic disease","volume":"58","author":"Achberger","year":"2014","journal-title":"Mol. Immunol."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Yong, F.L., Law, C.W., and Wang, C.W. (2013). Potentiality of a triple microRNA classifier: miR-193a-3p, miR-23a and miR-338-5p for early detection of colorectal cancer. BMC Cancer, 13.","DOI":"10.1186\/1471-2407-13-280"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"18122","DOI":"10.1074\/jbc.RA119.010144","article-title":"DNA methyltransferase 1-mediated CpG methylation of the miR-150-5p promoter contributes to fibroblast growth factor receptor 1-driven leukemogenesis","volume":"294","author":"Hu","year":"2019","journal-title":"J. Biol. Chem."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"502","DOI":"10.3109\/1354750X.2013.816777","article-title":"A comparative analysis of total serum miRNA profiles identifies novel signature that is highly indicative of metastatic melanoma: A pilot study","volume":"18","author":"Greenberg","year":"2013","journal-title":"Biomarkers"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jid.2019.06.126","article-title":"MicroRNA Ratios Distinguish Melanomas from Nevi","volume":"140","author":"Torres","year":"2020","journal-title":"J. Invest. Dermatol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.molmed.2014.06.005","article-title":"MicroRNAs in cancer: Biomarkers, functions and therapy","volume":"20","author":"Hayes","year":"2014","journal-title":"Trends Mol Med."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1586\/14737159.2015.1081058","article-title":"Micromarkers 2.0: An update on the role of microRNAs in cancer diagnosis and prognosis","volume":"15","author":"Ferracin","year":"2015","journal-title":"Expert. Rev. Mol. Diagn."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.aca.2011.05.025","article-title":"Analytical aspects of microRNA in diagnostics: A review","volume":"699","author":"Rodicio","year":"2011","journal-title":"Anal. Chim. Acta"},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Greenberg, E., Hershkovitz, L., Itzhaki, O., Hajdu, S., Nemlich, Y., Ortenberg, R., Gefen, N., Edry, L., Modai, S., and Keisari, Y. (2011). Regulation of cancer aggressive features in melanoma cells by microRNAs. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0018936"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Larrea, E., Sole, C., Manterola, L., Goicoechea, I., Armesto, M., Arestin, M., Caffarel, M.M., Araujo, A.M., Araiz, M., and Fernandez-Mercado, M. (2016). New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17050627"},{"key":"ref_77","first-page":"13249","article-title":"Expression of miR-203 is decreased and associated with the prognosis of melanoma patients","volume":"8","author":"Wang","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev-anchem-071114-040343","article-title":"MicroRNA Detection: Current Technology and Research Strategies","volume":"8","author":"Hunt","year":"2015","journal-title":"Annu Rev Anal Chem (Palo Alto Calif)"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1021\/acs.analchem.8b05909","article-title":"MicroRNA Detection Specificity: Recent Advances and Future Perspective","volume":"91","author":"Ouyang","year":"2019","journal-title":"Anal. Chem."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/1\/51\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T08:11:29Z","timestamp":1787127089000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/1\/51"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,23]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["diagnostics16010051"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics16010051","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,23]]}}}